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Breath analyses for medical applications (screening, biomarker discovery, biological process 
description, …) have been gaining more and more attention over the last couple of decades as 
evidences about links between volatile organic compound (VOC) breath signatures and specific 
diseases have been accumulating. 
Comprehensive two-dimensional gas chromatography GC×GC coupled to time-of-flight mass 
spectrometry (TOFMS) is a tool of choice to accurately describe complex VOC profiles of exhaled 
air. The use of high resolution/high accuracy (HR)TOFMS even further enhance proper analyte 
identification when putative markers of diseases can be isolated from cohort studies. A major 
point of issue however remains sample integrity as several external factors (e.g. ambient air, 
time of sampling, mode of sampling, …) can significantly impact the composition of the air 
patients exhale. 
In this study, we collected breath samples using Teddlar™ bags from patients suffering from 
lung cancer (n=15) as well as from healthy controls (n=15) over a period of 5 months. 
TD-GC×GC-TOFMS analyses were carried out to highlight prominent analytes in both classes of 
samples. Several univariate and multivariate data treatment approaches were investigated (e.g. 
Fisher ratio, dispersion boxes, principal component analysis and clustering) to reduce the 
weight of external confounding factors to a level that did not impact cohort differentiations 
anymore. These data mining approaches were further challenged by testing them on additional 
cohorts. Selected samples were analyzed by GC×GC-HRTOFMS to enhance our confidence in 
the identification of putative biomarkers. 
